English

Vaccine

Health news

Good vaccine response? Your blood might hold the secret

ADVERTISEMENT

ADVERTISEMENT

Health news

Ebola death toll in DR Congo outbreak rises to more than 2,000

The Ebola outbreak, which has hit the DRC's conflict-plagued eastern and northeastern regions, was declared on 15 May but is thought to have already been spreading for several weeks.

Health news

Trump signs order that calls for fewer childhood vaccines

The order recommends giving all childhood vaccinations at separate visits whenever feasible, which had earlier been blocked by a federal judge, and dividing the measles, mumps, and rubella vaccine into three distinct single injections

Health news

Medicines watchdog approves first-ever mRNA-based flu shot in the US

The US medicines regulator approved the first-ever mRNA-based vaccine in the US against flu for seniors.

Health news

Moderna starts human trials for Ebola vaccine amid Congo outbreak

Moderna has vaccinated the first participants in a trial for a Bundibugyo Ebola vaccine, as the Democratic Republic of Congo continues to battle its fastest-growing outbreak on record.

ADVERTISEMENT

Health news

First Bundibugyo Ebola vaccine to start human trials in the UK

Scientists in Oxford will start to test the world's first vaccine against Bundibugyo Ebola, as an outbreak of the rare virus strain continues to spread across Congo and Uganda.

Health news

Oxford professor: 'The next pandemic is not a matter of if, but when'

The Oxford professor who developed the first highly effective malaria vaccine explains what Covid taught us, why misinformation is still a threat and why Europe must invest more in public health

Health news

Billions of mRNA vaccine doses’ review underpins their effectiveness

A review of data covering billions of doses of mRNA vaccines has found "compelling" evidence that the technology is both safe and highly effective against infectious diseases, with researchers arguing that the focus should now shift to improving access.

The Big Question

Moderna CEO: ‘I worry deeply about bioterrorism’

Internationally renowned for their life-saving Covid vaccine, what is Moderna doing now? Their CEO joins us in the studio to discuss bioterrorism, pandemic preparedness and cancer treatment.

Health news

Scientists design first ‘universal vaccine’ with the help of AI

A new AI-designed vaccine capable of protecting against entire families of viruses could transform how the world prepares for a future pandemic.

Health news

Health body fast-tracks three Ebola vaccines as virus continues spread

Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread.

Health news

Why the Congo Ebola outbreak has no quick fix

The WHO has identified promising treatments and vaccines for the rare Ebola strain killing hundreds in the Democratic Republic of Congo, but none are ready yet.

Health news

Scientists race to develop hantavirus vaccine for new strain

A deadly hantavirus outbreak on a cruise ship has raised fears over emerging viruses with no cure or vaccine. The UK government had already commissioned researchers to develop what could become the world’s first hantavirus vaccine

Health news

Lyme disease vaccine shows strong results in clinical trial

Pfizer and Valneva's Lyme disease vaccine has shown promising results in clinical trials, paving the way for regulatory approval despite setbacks due to fewer cases than expected, according to the companies.

Health news

Expired vaccines given to 253 people in Spain's Basque Country

None of the victims - most of them infants - have had any adverse side effects.

Health news

Could a shingles vaccine help you live longer?

Besides protecting against the disease, the shingles vaccine could also be linked to slower biological ageing, a new study has found.

Health news

Vaccine for aggressive skin cancer shows promising results in trials

A personalised mRNA vaccine developed by Moderna and Merck shows lasting benefits for patients with high-risk skin cancer.